Your browser doesn't support javascript.
loading
Rare predicted deleterious FEZF2 variants are associated with a neurodevelopmental phenotype.
Garber, Alison; Weingarten, Lisa S; Abreu, Nicolas J; Elloumi, Houda Zghal; Haack, Tobias; Hildebrant, Clara; Martínez-Gil, Núria; Mathews, Jennifer; Müller, Amelie Johanna; Valenzuela Palafoll, Irene; Steigerwald, Connolly; Chung, Wendy K.
Affiliation
  • Garber A; Department of Pediatrics, Columbia University, New York, New York, USA.
  • Weingarten LS; Department of Pediatrics, Columbia University, New York, New York, USA.
  • Abreu NJ; Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
  • Elloumi HZ; GeneDx, Gaithersburg, Maryland, USA.
  • Haack T; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Hildebrant C; Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Martínez-Gil N; Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Mathews J; Medical Genetics Group, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Müller AJ; Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Valenzuela Palafoll I; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Steigerwald C; Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Chung WK; Medical Genetics Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Am J Med Genet A ; 194(7): e63578, 2024 07.
Article in En | MEDLINE | ID: mdl-38425142
ABSTRACT
FEZF2 encodes a transcription factor critical to neurodevelopment that regulates other neurodevelopment genes. Rare variants in FEZF2 have previously been suggested to play a role in autism, and cases of 3p14 microdeletions that include FEZF2 share a neurodevelopmental phenotype including mild dysmorphic features and intellectual disability. We identified seven heterozygous predicted deleterious variants in FEZF2 (three frameshifts, one recurrent missense in two independent cases, one nonsense, and one complete gene deletion) in unrelated individuals with neurodevelopmental disorders including developmental delay/intellectual disability, autism, and/or attention-deficit/hyperactivity. Variants were confirmed to be de novo in five of seven cases and paternally inherited from an affected father in one. Predicted deleterious variants in FEZF2 may affect the expression of genes that are involved in fate choice pathways in developing neurons, and thus contribute to the neurodevelopmental phenotype. Future studies are needed to clarify the mechanism by which FEZF2 leads to this neurodevelopmental disorder.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Phenotype / Neurodevelopmental Disorders / Intellectual Disability Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Am J Med Genet A Journal subject: GENETICA MEDICA Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Phenotype / Neurodevelopmental Disorders / Intellectual Disability Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Am J Med Genet A Journal subject: GENETICA MEDICA Year: 2024 Type: Article Affiliation country: United States